Education
About Us
Working with TipRanks
Follow Us
VistaGen Therapeutics (VTGN)
NASDAQ:VTGN
| Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 486.00K | $ 1.06M | $ -227.00K | $ 1.11M | $ 1.09M |
| Gross Profit | $ 486.00K | $ 1.06M | $ -227.00K | $ 1.11M | $ 1.09M |
| Operating Income | $ -55.97M | $ -33.02M | $ -59.27M | $ -47.78M | $ -17.93M |
| EBITDA | $ -55.34M | $ -32.45M | $ -58.74M | $ -47.05M | $ -17.44M |
| Net Income | $ -51.42M | $ -29.36M | $ -59.25M | $ -47.76M | $ -17.93M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 80.48M | $ 119.17M | $ 16.64M | $ 68.14M | $ 103.11M |
| Total Assets | $ 84.34M | $ 123.65M | $ 21.09M | $ 74.64M | $ 108.28M |
| Total Debt | $ 1.51M | $ 2.12M | $ 2.72M | $ 3.04M | $ 3.72M |
| Net Debt | $ -65.62M | $ -117.05M | $ -13.92M | $ -65.10M | $ -99.39M |
| Total Liabilities | $ 13.95M | $ 9.37M | $ 9.01M | $ 9.93M | $ 16.30M |
| Stockholders' Equity | $ 70.39M | $ 114.29M | $ 12.08M | $ 64.72M | $ 91.98M |
| Cash Flow | |||||
| Free Cash Flow | $ -42.29M | $ -25.87M | $ -49.93M | $ -45.46M | $ -12.35M |
| Operating Cash Flow | $ -42.10M | $ -25.81M | $ -49.72M | $ -45.26M | $ -12.07M |
| Investing Cash Flow | $ -13.15M | $ -61.00K | $ -740.30K | $ -200.40K | $ -275.40K |
| Financing Cash Flow | $ 3.21M | $ 128.40M | $ -1.04M | $ 10.48M | $ 114.10M |